ArticleMaterials today. Bio2025
Alkyl side-chain engineering enables significant suppression of conformational relaxation for improved near infrared-II imaging-guided uterine recanalization surgery and cancer phototheranostics.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tailoring NIR-II Fluorescence and Photothermal Properties via Side-Chain Engineering for Vascular Imaging and Image-Guided Tumor Therapy.Advanced healthcare materials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phototheranostics have recently aroused extreme attention due to its exceptional advantages. Developing a single agent synchronously sharing powerful absorption, high second near-infrared (NIR-II) fluorescence efficiency and photothermal conversion efficiency is urgently demand but extremely scarce. Herein, two kinds of NIR-II phototheranositc agents featuring aggregation-induced emission, NIR-II fluorescence imaging (FLI) and photothermal therapy (PTT) are constructed through constructing electron donor-acceptor (D-A) molecular skeleton with side-chain engineering. Profiting from sufficient molecular rotors, highly twisted configurations, large reorganization energy and high HRf values concentrating stretching/scissoring of alkyl chain, BBT2 is endowed with NIR-II fluorescence property and high photothermal conversion. The nanoparticles (NPs) fabricated with BBT2 exhibit significant NIR-II FLI-guided uterine cavity recanalization surgery and efficient PTT therapy under laser irradiation both in vitro and orthotopic 4T1 mice models. Transvaginal BBT2 NPs are highly effective in assessing uterine cavity patency in mice and the subsequent pregnancy rate with 6 months of follow-up after uterine cavity recanalization surgery is synchronously evaluated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.